Novartis AG (LTS:0QLR) Land And Improvements: CHF0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QLR Novartis AG LTS:0QLR
80 GF Score
Price CHF112.24
GF Value CHF106.93
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Novartis AG Land And Improvements?

Novartis AG LTS:0QLR +0.14% 80 Land And Improvements is CHF0 Mil as of Jun. 2026. GuruFocus rates LTS:0QLR with a GF Score™ of 80/100 and a GF Value™ of CHF106.93 (Fairly Valued). The stock has 2 warning signs investors should review.

Novartis AG's land and improvements for the quarter that ended in Jun. 2026 was CHF0 Mil.

Novartis AG's quarterly land and improvements declined from Dec. 2025 (CHF727 Mil) to Mar. 2026 (CHF0 Mil) but then stayed the same from Mar. 2026 (CHF0 Mil) to Jun. 2026 (CHF0 Mil).

Novartis AG's annual land and improvements declined from Dec. 2023 (CHF766 Mil) to Dec. 2024 (CHF756 Mil) and declined from Dec. 2024 (CHF756 Mil) to Dec. 2025 (CHF727 Mil).

Novartis AG Land And Improvements Historical Data

* Premium members only.

The historical data trend for Novartis AG's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG Land And Improvements Chart

Novartis AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Land And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 933.89 890.61 766.21 756.08 726.77

Novartis AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 726.77 0.00 0.00
LTS:0QLR
80GF Score
Novartis AG LTS:0QLR
Land And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novartis AG Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of CHF0 Mil mean?
Novartis AG (LTS:0QLR) has a Land And Improvements of CHF0 Mil as of Jun. 2026. Land and improvements records the total value of a company's land and improvements to it. View historical data on Novartis AG and its competitors.
Is Novartis AG's Land And Improvements too high?
Novartis AG's current Land And Improvements is CHF0 Mil. Overall, Novartis AG has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's Land And Improvements compare to LLY and JNJ?
Novartis AG's Land And Improvements of CHF0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Drug Manufacturers company?
A good Land And Improvements depends on the Drug Manufacturers industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on Novartis AG and its competitors. Novartis AG's current Land And Improvements is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Based on GuruFocus' analysis, Novartis AG (LTS:0QLR) is currently considered Fairly Valued. The stock's GF Value™ is CHF106.93, compared to a current price of CHF112.24 — trading 5% above its estimated fair value. The current Land And Improvements is CHF0 Mil. Novartis AG's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For Novartis AG (LTS:0QLR), the current Land And Improvements is CHF0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novartis AG (LTS:0QLR) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued. The current stock price of CHF112.24 is trading 5% above its estimated GF Value™ of CHF106.93. GuruFocus considers Novartis AG to be Fairly Valued.

Key valuation signals for LTS:0QLR:

  • Land And Improvements: CHF0 Mil
  • GF Value™: CHF106.93 vs. price of CHF112.24 (5% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the LTS:0QLR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
80GF Score

Get the complete analysis for LTS:0QLR

Land And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF112.24
Price
CHF106.93
GF Value